Discover the Future of RNA with NTx at Upcoming Industry Events

Get a first look at NTxscribe^®, a continuous flow mRNA in vitro transcription and purification system that brings cost effective and scalable RNA manufacturing to the market

RIO RANCHO, N.M.--(BUSINESS WIRE)--Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced that members of its senior leadership and technical teams will attend a lineup of industry conferences throughout November and December to preview its NTxscribe system, a benchtop, plug and play continuous flow mRNA IVT and purification system ahead of its full commercial launch.

NTxscribe is a first-of-its-kind IVT system that enables the production of RNA in a fraction of the time and cost compared to traditional IVT, using a proprietary hollow fiber bioreactor in conjunction with continuous flow principles. The biosynthetic platform offers a low cost, rapidly deployable, and vertically integrated manufacturing system, which allows mRNA manufacturing to scale from research and development quantities to commercial levels with a compact, economical footprint.

Here is the upcoming event schedule:

• Society for Immunotherapy of Cancer (SITC) 2024 – November 6-10, 2024, Houston
  • Booth #747
  • NTx attendees: James Coffin, Ph.D., President and CEO; Matthew Phillips, Senior Vice President, Business Development; Steven Evans, Ph.D., Chief Scientific Officer and Senior Vice President, R&D; Handy Yowanto, Vice President, Product Management; Kim Ramsey, Senior Director, Business Development
• 12^th International mRNA Health Conference – November 12-14, 2024, Boston & Virtual
  • Booth #37
  • NTx attendees: James Coffin, Ph.D., President and CEO; Matthew Phillips, Senior Vice President, Business Development; Kelleen Aguinaga, Vice President, Business Development; Nathan Duval, Ph.D., Director of Technical Operations; Alex Van Keulen, Field Application Scientist
• Alliance for mRNA Medicines (AMM) 1st Annual Meeting – November 13-15, 2024, Boston
  • NTx attendees: Matthew Phillips, Senior Vice President, Business Development; Kelleen Aguinaga, Vice President, Business Development; Nathan Duval, Ph.D., Director of Technical Operations
• Mayo Clinic RegenBio Summit 2024 – December 9-11, 2024, Ponte Vedra Beach, Florida
  • NTx attendees: Matthew Phillips, Senior Vice President, Business Development; Kim Ramsey, Senior Director, Business Development; Alex Van Keulen, Field Application Scientist

To schedule a meeting with the NTx team at one of these upcoming conferences for a preview of the NTxscribe system, please email [e-mail].

To learn more about NTxscribe, please visit https://ntxbio.com/reserve.

About NTx

Nature's Toolbox, Inc. (NTx) is advancing the healthcare industry with their next generation biomanufacturing solutions. NTx, based in Rio Rancho, New Mexico, is developing innovative systems like NTxpress^® and NTxscribe^® to enable manufacturing of mRNA vaccines and protein therapeutics in an eco-friendly and sustainable way. These easily scalable processes enable NTx’s platform to scale from personalized medicine dosage to pandemic volume. To learn more about their game-changing approach, visit their website at https://www.ntxbio.com.